NCT06600945 is a clinical trial of Cataract surgery in Peribulbar Anesthesia, sponsored by Dalia yousry Mohamed elsayed.

Who is sponsoring NCT06600945?

NCT06600945 is sponsored by Dalia yousry Mohamed elsayed.

What drugs are being tested in NCT06600945?

Interventions in NCT06600945: Cataract surgery.

What condition does NCT06600945 study?

NCT06600945 studies Peribulbar Anesthesia.

Is NCT06600945 still recruiting?

NCT06600945 is currently recruiting now. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT06600945

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic

Recruiting now Last updated 19 September 2024

What this trial tests

trial testing Cataract surgery in Peribulbar Anesthesia in 180 participants. Currently enrolling.

Timeline

1 February 2023

Primary endpoint
22 April 2024

1 April 2025

Quick facts

Lead sponsor	Dalia yousry Mohamed elsayed
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	180
Start date	1 February 2023
Primary completion	22 April 2024
Estimated completion	1 April 2025
Sites	1 location across Egypt

Drugs / interventions tested

Cataract surgery — full drug profile →

Conditions studied

Peribulbar Anesthesia — all drugs for Peribulbar Anesthesia →

Sponsor

Dalia yousry Mohamed elsayed

Who can join

Adults 20 to 80, any sex, with Peribulbar Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effects of adding magnesium sulfate to atracurium with local anesthetic mixture on akinesia of globe and eyelid regarding onset and duration in cataract surgery using peribulbar technique

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cataract surgery

Trials testing the same drug.

NCT06505434 — A Dynamic Study of Pupil Diameter After Artificial Lens Implantation in Patients With High Myopia · not yet recruiting
NCT06400745 — Clareon PanOptix Pro vs. Clareon PanOptix - Study A · NA · completed
NCT05776095 — Evaluation of Safety and Performance Outcomes of Eyedeal IOL Implantation After Cataract Removal · NA · unknown
NCT05796674 — Clareon IOL Retrospective Data Collection · completed
NCT04074954 — A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06600945 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dalia yousry Mohamed elsayed
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06600945.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing